| Ident. | Authors (with country if any) | Title |
|---|
| 000006 |
Santiago Perez-Lloret [France] ; María Ver Nica Rey [France] ; James Crispo [Canada] ; Daniel Krewski [Canada] ; Marise Lapeyre-Mestre [France] ; Jean-Louis Montastruc [France] ; Olivier Rascol [France] | Risk of heart failure following treatment with dopamine agonists in Parkinson's disease patients |
| 000007 |
Barbara S. Connolly [Canada] ; Anthony E. Lang [Canada] | Pharmacological Treatment of Parkinson Disease A Review |
| 000045 |
Dimitri Ryczko [Canada] ; Réjean Dubuc [Canada] | The Multifunctional Mesencephalic Locomotor Region |
| 000065 |
Susan H. Fox [Canada] | Non-dopaminergic Treatments for Motor Control in Parkinson's Disease |
| 000066 |
Leigh Christopher [Canada] ; Antonio P. Strafella [Canada] | Neuroimaging of brain changes associated with cognitive impairment in Parkinson's disease |
| 000069 |
Nathan Herrmann [Canada] ; Connie Marras [Canada] ; Hadas D. Fischer [Canada] ; XUESONG WANG [Canada] ; Geoff M. Anderson [Canada] ; Paula A. Rochon [Canada] | Management of Neuropsychiatric Symptoms in Long-Term Care Residents with Parkinson's Disease: A Retrospective Cohort Study |
| 000072 |
Cristina Nombela [Royaume-Uni] ; Laura E. Hughes [Royaume-Uni] ; Adrian M. Owen [Canada] ; Jessica A. Grahn [Canada] | Into the groove: Can rhythm influence Parkinson's disease? |
| 000077 |
Prasanth Puthanveetil [Canada] ; Brian Rodrigues [Canada] | Glucocorticoid Excess Induces Accumulation of Cardiac Glycogen and Triglyceride: Suggested Role for AMPK : Metabolic Syndrome and Cardiovascular Health: A Look Beyond the Horizon |
| 000080 |
Rodolfo Delgado-Lezama [Mexique] ; Emanuel Loeza-Alcocer [Mexique] ; Carmen Andres [Mexique] ; Justo Aguilar [Mexique] ; Pierre A. Guertin [Canada] ; Ricardo Felix [Mexique] | Extrasynaptic GABAA Receptors in the Brainstem and Spinal Cord: Structure and Function |
| 000094 |
Mee-Sook Song [Canada] ; Dmitriy Matveychuk [Canada] ; Erin M. Mackenzie [Canada] ; Maryana Duchcherer [Canada] ; Darrell D. Mousseau [Canada] ; Glen B. Baker [Canada] | An update on amine oxidase inhibitors: Multifaceted drugs |
| 000108 |
Alexander Klein [Royaume-Uni] ; Lori-Ann R. Sacrey [Canada] ; Ian Q. Whishaw [Canada] ; Stephen B. Dunnett [Royaume-Uni] | The use of rodent skilled reaching as a translational model for investigating brain damage and disease |
| 000128 |
Chaim M. Bell [Canada] ; Stacey S. Brener [Canada] ; Rebecca Comrie [Canada] ; Geoffrey M. Anderson [Canada] ; Susan E. Bronskill [Canada] | Quality Measures for Medication Continuity in Long-Term Care Facilities, Using a Structured Panel Process |
| 000131 |
Anthony N. Carlsen [Canada] ; Dana Maslovat [Canada] ; Ian M. Franks [Canada] | Preparation for voluntary movement in healthy and clinical populations: Evidence from startle : Neurophysiology of the Brainstem |
| 000141 |
John S. Yeomans [Canada] | Muscarinic Receptors in Brain Stem and Mesopontine Cholinergic Arousal Functions |
| 000167 |
Olena Babenko [Canada] ; Igor Kovalchuk [Canada] ; Gerlinde A. Metz [Canada] | Epigenetic programming of neurodegenerative diseases by an adverse environment |
| 000225 |
Amit Bar-Or [Canada] ; Peter Rieckmann [Canada] ; Anthony Traboulsee [Canada] ; V. Wee Yong [Canada] | Targeting Progressive Neuroaxonal Injury: Lessons from Multiple Sclerosis |
| 000231 |
J. H. J. Allum [Suisse] ; K.-S. Tang [Suisse, Pays-Bas] ; M. G. Carpenter [Canada] ; L. B. Oude Nijhuis [Pays-Bas] ; B. R. Bloem [Pays-Bas] | Review of first trial responses in balance control: Influence of vestibular loss and Parkinson's disease |
| 000268 |
Kaitlyn P. Roland [Canada] ; Jennifer M. Jakobi [Canada] ; Colin Powell [Canada] ; Gareth R. Jones [Canada] | Factors related to functional independence in females with Parkinson's disease: A systematic review |
| 000269 |
Karin Wirdefeldt [Suède, États-Unis] ; Hans-Olov Adami [Suède] ; Philip Cole [États-Unis] ; Dimitrios Trichopoulos [États-Unis] ; Jack Mandel [Canada] | Epidemiology and etiology of Parkinson's disease: a review of the evidence |
| 000270 |
Edward A. Neuwelt [États-Unis] ; Björn Bauer [États-Unis] ; Christoph Fahlke [Allemagne] ; Gert Fricker [Allemagne] ; Constantino Iadecola [États-Unis] ; Damir Janigro [États-Unis] ; Luc Leybaert [Belgique] ; Zoltán Molnar [Royaume-Uni] ; Martha E. O'Donnell [États-Unis] ; John T. Povlishock [États-Unis] ; Norman R. Saunders [Australie] ; Frank Sharp [États-Unis] ; Danica Stanimirovic [Canada] ; Ryan J. Watts [États-Unis] ; Lester R. Drewes [États-Unis] | Engaging neuroscience to advance translational research in brain barrier biology |
| 000295 |
Matthias Kliegel [Allemagne] ; Mareike Altgassen [Allemagne] ; Alexandra Hering [Allemagne] ; Nathan S. Rose [Canada] | A process-model based approach to prospective memory impairment in Parkinson's disease |
| 000370 |
Edeltraut Kröger [Pays-Bas, Canada] ; Rob Van Marum [Pays-Bas] ; Patrick Souverein [Pays-Bas] ; Toine Egberts [Pays-Bas] | Discontinuation of Cholinesterase Inhibitor Treatment and Determinants thereof in the Netherlands: A Retrospective Cohort Study |
| 000415 |
Basil G. Bereza [Canada] ; Marcio Machado [Canada] ; Thomas R. Einarson [Canada] | Systematic Review and Quality Assessment of Economic Evaluations and Quality-of-Life Studies Related to Generalized Anxiety Disorder |
| 000422 |
S. Bourgault [Canada, France] ; D. Vaudry [France] ; A. Dejda [Canada, France] ; N. D. Doan [Canada, France] ; H. Vaudry [France] ; A. Fournier [Canada, France] | Pituitary Adenylate Cyclase-Activating Polypeptide: Focus on Structure-Activity Relationships of a Neuroprotective Peptide |
| 000431 |
Ali Samii [États-Unis] ; Mahyar Etminan [Canada] ; Matthew O. Wiens [Canada] ; Siavash Jafari [Canada] | NSAID Use and the Risk of Parkinson's Disease: Systematic Review and Meta-Analysis of Observational Studies |
| 000503 |
Magdalena Szczerbowska-Boruchowska [Pologne] | X-ray fluorescence spectrometry, an analytical tool in neurochemical research |
| 000528 |
J.-F. Gagnon [Canada] ; D. Petit [Canada] ; V. Latreille [Canada] ; J. Montplaisir [Canada] | Neurobiology of Sleep Disturbances in Neurodegenerative Disorders |
| 000546 |
Frank J. S. Lee [Canada] ; FANG LIU [Canada] | Genetic factors involved in the pathogenesis of Parkinson's disease |
| 000576 |
S. Potvin [Canada] ; S. Grignon [Canada] | Dopamine et douleur : une revue de littérature : Fibromyalgie |
| 000580 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The role of anti-inflammatory agents in Parkinson's disease |
| 000581 |
Edith G. Mcgeer [Canada] ; Patrick L. Mcgeer [Canada] | The role of anti-inflammatory agents in Parkinson's disease |
| 000606 |
I. S. H. Cadden [Canada] ; N. Partovi [Canada] ; E. M. Yoshida [Canada] | Review article : possible beneficial effects of coffee on liver disease and function |
| 000621 |
Daniel Levesque [Canada] ; Claude Rouillard [Canada] | Nur77 and retinoid X receptors : crucial factors in dopamine-related neuroadaptation |
| 000656 |
M. Berk [Australie] ; S. Dodd [Australie] ; M. Kauer-Sant'Anna [Canada] ; G. S. Malhi [Australie] ; M. Bourin [France] ; F. Kapczinski [Brésil] ; T. Norman [Australie] | Dopamine dysregulation syndrome : implications for a dopamine hypothesis of bipolar disorder |
| 000732 |
Charles Ramassamy [Canada] | Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases : A review of their intracellular targets |
| 000762 |
R. A. Bressan [Brésil] ; J. A. Crippa [Brésil] | The role of dopamine in reward and pleasure behaviour : review of data from preclinical research |
| 000782 |
Shawn Hayley [Canada] ; Hymie Anisman [Canada] | Multiple mechanisms of cytokine action in neurodegenerative and psychiatric states: Neurochemical and molecular substrates : The role of cytokines in neurodegeneration and psychiatric conditions: Multiple mechanisms of action |
| 000793 |
Bianca Marchetti [Italie] ; Pier Andrea Serra [Italie] ; Cataldo Tirolo [Italie] ; Francesca L'Episcopo [Italie] ; Salvo Caniglia [Italie] ; Florinda Gennuso [Italie] ; Nuccio Testa [Italie] ; Egidio Miele [Italie] ; Speranza Desole [Italie] ; Nicholas Barden [Canada] ; Maria Concetta Morale [Italie] | Glucocorticoid receptor-nitric oxide crosstalk and vulnerability to experimental parkinsonism : pivotal role for glia-neuron interactions |
| 000822 |
Brad Hagen [Canada] ; Chris Armstrong Esther [Canada] ; Roland Ikuto [Canada] ; Robert J. Williams [Canada] ; Carole-Lynne Le Navenec [Canada] ; Morgan Aho | Antipsychotic drug use in Canadian long-term care facilities : prevalence, and patterns following resident relocation |
| 000834 |
L. Clark [Royaume-Uni] ; R. Cools [Royaume-Uni] ; T. W. Robbins [Royaume-Uni] | The neuropsychology of ventral prefrontal cortex: Decision-making and reversal learning |
| 000839 |
Christopher J. Macdonald [États-Unis] ; Warren H. Meck [États-Unis] | Systems-level integration of interval timing and reaction time |
| 000845 |
Dominique Petit [Canada] ; Jean-Francois Gagnon [Canada] ; Maria Livia Fantini [Canada] ; Luigi Ferini-Strambi [Italie] ; Jacques Montplaisir [Canada] | Sleep and quantitative EEG in neurodegenerative disorders |
| 000858 |
Raul De La Fuente-Fernandez [Canada, Espagne] ; Michael Schulzer [Canada] ; A. Jon Stoessl [Canada] | Placebo mechanisms and reward circuitry: Clues from Parkinson's disease |
| 000909 |
Roger F. Butterworth [Canada] | Thiamin deficiency and brain disorders |
| 000925 |
Erwan Bezard [France] ; Christian E. Gross [France] ; Jonathan M. Brotchie [Canada] | Presymptomatic compensation in Parkinson's disease is not dopamine-mediated |
| 000956 |
Bhagu R. Bhavnani [Canada] | Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's |
| 000967 |
Mahyar Etminan [Canada] ; Sudeep Gill [Canada] ; Ali Samii [États-Unis] | Comparison of the risk of adverse events with Pramipexole and ropinirole in patients with Parkinson's disease a meta-analysis |
| 000989 |
H. Uri Saragovi [Canada] ; Maria Clara Zaccaro [Canada] | Small molecule peptidomimetic ligands of neurotrophin receptors, identifying binding sites, activation sites and regulatory sites |
| 000993 |
Vincenzo Di Matteo [Italie] ; Marisa Cacchio [Italie] ; Camillo Di Giulio [Italie] ; Ennio Esposito [Italie] | Role of serotonin2C receptors in the control of brain dopaminergic function |
| 000995 |
Andrew J. Thompson [Royaume-Uni] ; Colin J. Barrow [Canada] | Protein conformational misfolding and amyloid formation: Characteristics of a new class of disorders that include Alzheimer's and Prion diseases |
| 000A22 |
Michel Cyr [Canada] ; Frederic Calon [Canada] ; Marc Morissette [Canada] ; Thérèse Di Paolo [Canada] | Estrogenic modulation of brain activity: implications for schizophrenia and Parkinson's disease |
| 000A78 |
Doris J. Doudet [Canada] | Monitoring disease progression in Parkinson's disease |
| 000B50 |
James N. Oak [Canada] ; John Oldenhof [Canada] ; Hubert H. M. Van Tol [Canada] | The dopamine D4 receptor : one decade of research |
| 000B54 |
A. E. Lang [Canada] ; LANGSTON ; RASCOL ; BROTCHIE ; BENABID ; MELAMED ; BONUCELLI ; OLANOW ; OBESO ; GIMENEZ-ROLDAN ; RAJPUT ; FAHN ; NUTT ; BROOKS ; CHASE | Surgery for levodopa-induced dyskinesias. Discussion |
| 000B55 |
A. E. Lang [Canada] | Surgery for Parkinson disease : A critical evaluation of the state of the art |
| 000B56 |
I. Mendez [Canada] ; K. A. Baker [Canada] ; M. Hong [Canada] | Simultaneous intrastriatal and intranigral grafting (double grafts) in the rat model of Parkinson's disease |
| 000B64 |
S. S. Gill [Canada] ; R. W. Mueller [Canada] ; P. F. Mcguire [Canada] ; O. M. Pulido [Canada] | Potential target sites in peripheral tissues for excitatory neurotransmission and excitotoxicity |
| 000B69 |
André Parent [Canada] ; Fumi Sato [Canada] ; YING WU [Canada] ; Julie Gauthier [Canada] ; Martin Levesque [Canada] ; Martin Parent [Canada] | Organization of the basal ganglia : the importance of axonal collateralization |
| 000B87 |
Nancy J. Rothwell [Royaume-Uni] ; Giamal N. Luheshi [Canada] | Interleukin I in the brain : biology, pathology and therapeutic target |
| 000B96 |
M. Cyr [Canada] ; F. Calon [Canada] ; M. Morissette [Canada] ; M. Grandbois [Canada] ; S. Callier [Canada, France] ; T. Di Paolo [Canada] | Drugs with estrogen-like potency and brain activity : Potential therapeutic application for the CNS |
| 000B97 |
Frédéric Calon [Canada] ; ABDALLAH HADJ TAHAR [Canada] ; Pierre J. Blanchet [Canada] ; Marc Morissette [Canada] ; Richard Grondin [Canada] ; Martin Goulet [Canada] ; Jean-Pierre Doucet [Canada] ; George S. Robertson [Canada] ; Eric Nestler [États-Unis] ; Thérèse Di Paolo [Canada] ; Paul J. Bedard [Canada] | Dopamine-receptor stimulation : biobehavioral and biochemical consequences |
| 000C26 |
M. Grossman [États-Unis] | Sentence processing in Parkinson's disease |
| 000C32 |
Nicolaas Paul L. G. Verhoeff [Canada] | Radiotracer imaging of dopaminergic transmission in neuropsychiatric disorders |
| 000C38 |
M. Guttman [Canada] ; O. Suchowersky [Canada] | Parkinson's disease management : Towards a new paradigm |
| 000C47 |
T. Mendis [Canada] ; O. Suchowersky [Canada] ; A. Lang [Canada] ; S. Gauthier [Canada] | Management of Parkinson's disease : A review of current and new therapies |
| 000C59 |
T. A. Reader [Canada] ; K. M. Dewar [Canada] | Effects of denervation and hyperinnervation on dopamine and serotonin systems in the rat neostriatum : implications for human Parkinson's disease |
| 000C78 |
A. Hadjtahar [Canada] ; P. J. Bedard [Canada] | Comprendre et traiter les dyskinésies induites par la levodopa |
| 000C83 |
E. G. Mcgeer [Canada] ; P. L. Mcgeer [Canada] | The future use of complement inhibitors for the treatment of neurological diseases |
| 000C91 |
A. E. Lang [Canada] ; A. M. Lozano [Canada] | Parkinson's disease: First of two parts |
| 000D23 |
M. Manford [Royaume-Uni] ; F. Andermann [Canada] | Complex visual hallucinations clinical and neurobiological insights |
| 000D35 |
| Le traitement neurochirurgical de la maladie de Parkinson et autres mouvements anormaux |
| 000D44 |
| Greffes |
| 000D45 |
A. Destee [France] | Données séméiologiques et principes actuels du traitement médical |
| 000D47 |
A. Parent [Canada] ; F. Cicchetti [Canada] | Anatomie et physiopathologie des ganglions de la base |
| 000D51 |
L. Thorpe [Canada] | The treatment of psychotic disorders in late life |
| 000D71 |
J. S. Bains [Canada] ; C. A. Shaw [Canada] | Neurodegenerative disorders in humans: the role of glutathione in oxidative stress-mediated neuronal death |
| 000D73 |
V. Mehta [Canada] ; J. Spears [Canada] ; I. Mendez [Canada] | Neural transplantation in Parkinson's disease |
| 000D89 |
M. Novak [Hongrie, Canada] ; C. M. Shapiro [Canada] | Drug-induced sleep disturbances : Focus on nonpsychotropic medications |
| 000E01 |
K. Rabheru [Canada] ; E. Persad [Canada] | A review of continuation and maintenance electroconvulsive therapy |
| 000E07 |
MANOHAR LAL THAKUR [Canada] ; UMA SHANKAR SRIVASTAVA [Canada] | Vitamin-E metabolism and its application |
| 000E41 |
M. D. Berry [Canada] ; A. V. Juorio [Canada] ; X.-M. Li [Canada] ; A. A. Boulton [Canada] | Aromatic L-amino acid decarboxylase : A neglected and misunderstood enzyme |
| 000E44 |
M.-A. Bedard [Canada] ; M. Panisset | Neurochimie des troubles cognitifs dans la maladie de Parkinson |
| 000E72 |
P. J. Bedard [Canada] | D-1 receptor in neurology and psychiatry : an overview : The role of D-1 dopamine receptors in neurology and psychiatry |
| 000E74 |
S. Cohen [Canada] ; M. Freedman | Cognitive and behavioral changes in the Parkinson-plus syndromes |
| 000E83 |
M. Filion [Canada] ; L. Tremblay ; M. Matsumura ; H. Richard | Focalisation dynamique de la convergence informationnelle dans les noyaux gris centraux |
| 000E90 |
K. H. Jhamandas [Canada] ; R. J. Boegman [Canada] ; R. J. Beninger | The 1993 Upjohn Award Lecture. Quinolinic acid induced brain neurotransmitter deficits : modulation by endogenous excitotoxin antagonists |
| 000F00 |
P. H. Yu [Canada] | Pharmacological and clinical implications of MAO-B inhibitors |
| 000F08 |
D. B. Calne [Canada] | Is idiopathic parkinsonism the consequence of an event or a process ? |
| 000F26 |
M. S. Pollanen [Canada] ; D. W. Dickson ; C. Bergeron | Pathology and biology of the Lewy body |
| 000F95 |
J. L. Cummings [Canada] | Depression and Parkinson's disease : a review |
| 000F98 |
D. B. Calne [Canada] ; B. J. Snow ; C. Lee | Criteria for diagnosing Parkinson's disease |
| 001028 |
J. Poirier [Canada] ; S. Kogan ; S. Gauthier | Environment, genetics and idiopathic Parkinson's disease |
| 001045 |
A. Fine | Transplantation of adrenal tissue into the central nervous system |
| 001067 |
P. Seeman ; H. B. Niznik | Dopamine receptors and transporters in Parkinson's disease and schizophrenia |
| 001077 |
A. W. R. Jones ; J. S. Richardson | Alzheimer's disease : clinical and pathological characteristics |
| 001099 |
J. G. Milton ; A. Longtin ; A. Beuter ; M. C. Mackey ; L. Glass | Complex dynamics and bifurcations in neurology |
| 001146 |
A. E. Lang | Manipulating the dopaminergic system in Parkinson's disease |
